A Study to Investigate GB-0895 Adjunctive Therapy in Adults and Adolescents With Severe Uncontrolled Asthma (SOLAIRIA-1)

ClinicalTrials.gov ID: NCT07276724

Public ClinicalTrials.gov record NCT07276724. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

View official ClinicalTrials.gov record → Back to search

ClinicalTrials.gov public records Last synced Apr 28, 2026, 12:27 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study to Assess the Efficacy and Safety of GB-0895 Adjunctive Therapy in Adults and Adolescents With Severe Uncontrolled Asthma

Study identification

NCT ID: NCT07276724
Recruitment status: Recruiting
Study type: Interventional
Phase: Phase 3
Lead sponsor: Generate Biomedicines; Industry
Enrollment: 786 participants

Conditions and interventions

Conditions

Severe Asthma

Interventions

GB-0895 Drug
Placebo Drug

Drug

Eligibility (public fields only)

Age range: 12 Years to 80 Years
Sex: All
Healthy volunteers: Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date: Dec 2, 2025
Primary completion: Nov 30, 2028
Completion: Nov 30, 2028
Last update posted: Apr 26, 2026

2025 – 2028

United States locations

U.S. sites: 27
U.S. states: 9
U.S. cities: 25

Facility	City	State	ZIP	Site status
Research Site 23	Northridge	California	91324	Recruiting
Research Site 26	Pasadena	California	91105	Recruiting
Research Site 13	West Hills	California	91307	Recruiting
Research Site 15	Colorado Springs	Colorado	80923	Recruiting
Research Site 12	Doral	Florida	33122	Recruiting
Research Site 14	Gainesville	Florida	32607	Recruiting
Research Site 03	Hialeah	Florida	33016	Recruiting
Research Site 25	Kendall	Florida	33176	Recruiting
Research Site 04	Miami	Florida	33126	Recruiting
Research Site 01	Miami Lakes	Florida	33014	Recruiting
Research Site 08	North Miami	Florida	33169	Recruiting
Research Site 10	Palm Springs	Florida	33461	Recruiting
Research Site 02	Tampa	Florida	33613	Recruiting
Research Site 18	Rincon	Georgia	31326	Recruiting
Research Site 16	Baltimore	Maryland	21237	Recruiting
Research Site 20	Towson	Maryland	21204	Recruiting
Research Site 06	Flint	Michigan	48504	Recruiting
Research Site 27	Gastonia	North Carolina	28054	Recruiting
Research Site 24	Amarillo	Texas	79106	Recruiting
Research Site 19	Baytown	Texas	77521	Recruiting
Research Site 07	Dallas	Texas	75230	Recruiting
Research Site 17	Dallas	Texas	75254	Recruiting
Research Site 11	Houston	Texas	77084	Recruiting
Research Site 09	Houston	Texas	77099	Recruiting
Research Site 22	Kerrville	Texas	78028	Recruiting
Research Site 05	Lewisville	Texas	75057	Recruiting
Research Site 21	Riverton	Utah	84096	Recruiting

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows: Public field values for ClinicalTrials.gov record NCT07276724, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do: No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from: Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh: Last update posted Apr 26, 2026 · Synced Apr 28, 2026

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT07276724 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →